The objective of this study is to investigate the effect of different doses of intravenous
immunoglobulin (IVIG) (1g/kg once, 1g/kg twice, 2g/kg once) for Kawasaki disease (KD) in a
multicentre, prospective,randomised trial.
Phase:
Phase 3
Details
Lead Sponsor:
Children's Hospital of Fudan University
Collaborators:
Children's Hospital of Shanghai Jiaotong University Shanghai Children's Hospital Shanghai Children's Medical Center